Matched Pair Antibody Development

About Native Antigen Company

The Native Antigen Company, founded in 2012 and based in Oxford, UK, is a leading provider of premium infectious disease reagents, including antigens and antibodies. It operates a hybrid business model, selling catalog products and offering extensive contract development and manufacturing services (CDMO) for diagnostic and vaccine R&D. Owned by LGC Clinical Diagnostics, the company's core strength lies in its proprietary VirtuE™ expression platform, which produces accurately folded and glycosylated proteins essential for advanced research and assay development.

Therapeutic Areas